Name: Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature (Video) | JoVE Journal
Uploaded: 2025-01-24T13:20:00.000+00:00
Duration: 5 min 54 s
Description: Learn to quantify adherent leukocytes in retinal vasculature using fluorescence microscopy and concanavalin A perfusion in mice. This method enables assessment of inflammation and therapeutic efficacy in diabetic retinopathy research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by National Institutes of Health (NIH) Grants R01EY022938, R01EY022938-S1, and K99EY034928. The authors acknowledge services of the CWRU (P30EY11373) and UCI (P30EY034070) Visual Science Research Center Cores, as well as departmental support from an unrestricted grant from Research to Prevent Blindness to the Gavin Herbert Eye Institute at the University of California Irvine.

The protocol has been reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at the University of California Irvine and conforms to governmental regulations regarding the care and use of laboratory animals. There are no stop points in this protocol. The average time per mouse is 30 min.
1. Preparing the perfusion stage
<ol>
	<li>Warm up the 0.9% saline bag and concanavalin A solution in a 37 oC water bath for 20-30 min before use. 
	NOTE: Protect concanavalin A from light exposure (cover with foil).</li>
	<li>Set up a tray to contain blood and liquids from dripping on the surface where the procedure will take place. On top of the tray, place a heating pad covered with an absorbent bench underpad or any absorbent material. 
	NOTE: The goal is to avoid the mouse&#39;s body losing heat during the procedure, because cooling makes&#160;more difficult to remove blood during perfusion.</li>
</ol>
2. Setting up the pressure infuser
<ol>
	<li>Connect in series the bag of 0.9% saline, the I.V. catheter set, a 4-way valve stopcock, and the gavage needle.</li>
	<li>Insert the 0.9% saline bag between the netting and the air bladder of the pressure infuser. Hang the saline bag on the hook located on the back of the air bladder. Use the I.V. pole loop to hang the pressure infuser in the I.V. pole.</li>
	<li>Purge the lines and ports of all air bubbles by letting the system open (run) for a couple of minutes and set the flow rate to 18-20 mL/min24. To inflate the pressure infuser air bladder, turn the stopcock handle to point toward the open stopcock vent, then pump the inflation bulb until the pressure gauge indicates the desired pressure. Re-adjust the pressure before perfusing each mouse. To deflate, turn the stopcock handle straight down towards the inflation bulb. 
	NOTE: If the 0.9% saline bag is new, usually 150 mmHg pressure delivers the desired flow rate; however, the pressure should be adjusted empirically due to variations in pressure infuser brands and over the period of use of the 0.9% saline bag.</li>
	<li>Attach a 10 mL syringe filled with warmed concanavalin A solution to the 4-way valve. 
	NOTE: Protect the syringe from light exposure (cover with foil).</li>
</ol>
3. Anesthesia
<ol>
	<li>Deliver anesthesia by intraperitoneal (I.P.) injection of Ketamine:Xylazine; the most widely used dose for mouse surgery/procedure is 100:10 mg/kg body weight25. Assess anesthesia by pedal reflex (firm toe pinch). 
	NOTE: This dose provides an onset of 4-6 min with a 45-60 min duration of surgical anesthesia. The anesthetic cocktail can be stored at room temperature for a maximum of 2 weeks.</li>
</ol>
4. Transcardial perfusion and staining with concanavalin A
<ol>
	<li>Place the mouse on the perfusion stage in the supine position to allow for exposure of the thoracic&#160;and abdominal cavity.</li>
	<li>Visually identify the xiphoid process, and with the hemostat in the dominant hand, pin the skin and lock it. Once the hemostat is secured, transfer it to the nondominant hand and lift the skin.</li>
	<li>Use scissors in the dominant hand and cut, in&#160;a 90&#176; angle to the spine, a patch of skin to reveal the outer abdominal wall.</li>
	<li>With the xiphoid process and the rib cage now visible, dissect through the abdominal wall bilaterally, taking care to avoid cutting any organs or major vessels.</li>
	<li>With the diaphragm now visible, visualize the heart ventricles and lungs through the diaphragm. Using the tip of the scissors, cut through the diaphragm in one of the flanks, close to the spine, taking care to avoid cutting any organs or major vessels. 
	NOTE: This &#34;hole&#34; in the diaphragm will equilibrate the negative intrathoracic pressure with the atmospheric pressure, and a pneumothorax will occur collapsing the lungs and retracting the heart, facilitating the dissection of the diaphragm without damaging the lungs or the heart.</li>
	<li>Continue dissecting through the ribs and parallel to the lungs to create a chest &#34;flap&#34;. Release the hemostat and cut the xiphoid process in the sagittal plane. Gently wide open the xiphoid process manually. Observe the four chambers of the heart.</li>
	<li>With the nondominant hand and using forceps, grasp the heart near its apex. With the dominant hand, hold the gavage needle (attached to the I.V. catheter) and puncture the apex of the heart. To avoid full perforation of the left ventricle or reaching the pulmonary vasculature and then poor perfusion of the systemic vasculature, check the placement of the end of the ball tip of the gavage needle, which should be at the edge of the site of puncture slightly protruding from the heart. Clamp the gavage needle in place using&#160;curved mosquito forceps or simply hold it by hand while manipulating the I.V. stopcock.</li>
	<li>Open the stopcock to the 0.9% saline and almost simultaneously, cut open the right atrium&#160;with scissors; perfuse for 2-3 min. During the perfusion time, gently move the needle from side to side and up and down to reduce kinking of the vasculature and increase blood exit from the heart.</li>
	<li>After perfusing with saline, turn the stopcock handle to shut off flow from the saline and allow flow from the syringe to the gavage needle. Perfuse by hand with the concanavalin A solution at a steady state rate. Ensure the 10 mL of concanavalin A solution is dispensed in 30-35 s.</li>
	<li>After perfusing with concanavalin A, turn the valve to shut off flow from the syringe and allow flow from the 0.9% saline to the gavage needle again. Perfuse with the 0.9% saline solution for an additional 2-3 min. Remove the gavage needle from the heart. 
	NOTE: The concanavalin A suggested in this protocol is conjugated to fluorescein (green); however, concanavalin A attached to other fluorochromes is also available.</li>
</ol>
5. Enucleation and isolation of fresh retina
<ol>
	<li>Turn the mouse on its side and, using the nondominant hand, place the index finger and thumb on the superior and inferior eyelids, respectively. Gently retract the eyelids and skin with fingers and proptose the eye, making it partially bulge out of the socket.</li>
	<li>While the eye is proptosed, use curved scissors in the dominant hand and scoop under the eye in&#160;a 45&#176; angle. Cut the muscular attachment and optic nerve. Using the same scissors as a spatula, transfer the eye to a small container or directly to the stage of the dissecting microscope. 
	NOTE: Be careful not to cut off the back of the eye and avoid pulling the eye during this step.</li>
	<li>Place the eye on a dental wax to open the globe. Under the dissecting microscope and using the nondominant hand, hold the scleral fold or the muscle remnants still attached externally to the posterior eye with micro-forceps, and orient the eye so that the cornea faces to a side. 
	NOTE: To prevent the eye from moving/sliding while opening the globe, a piece of wet lint-free tissue can be placed on top of the dental wax.</li>
	<li>With one of the sharp corners of a Teflon-coated razor blade, make an incision 1-2 mm behind and parallel to the limbus (cornea-sclera junction). Hold the scleral fold or muscle with the micro-forceps, and draw the blade across the limbus with minimal downward force. Continue to cut with the razor to totally separate the anterior segment (cornea, iris, lens, and vitreous) from the posterior segment (eye cup). 
	NOTE: Do not saw back and forth.</li>
	<li>Transfer the bisected eye cup to a small Petri dish with PBS. 
	NOTE: Avoid contact of the retina with the tissue paper (note in step 5.3) since it will tightly stick to the paper and become essentially impossible to recover.</li>
	<li>Grab a scleral fold or the remaining muscle on the outside of the sclera with micro-forceps. Completely detach the retina from the sclera by breaking all the connections at the limbus around the perimeter of the eye cup using a micro-spatula. Scoop the retina out from the sclera with the micro-spatula. If the retina is still attached to the sclera by the optic nerve, slip the micro-scissors between the retina and sclera to cut the optic nerve.</li>
	<li>Remove any remnants of vitreous and ciliary muscle in the periphery of the retina. Immediately transfer the isolated retina to a slide with some PBS. 
	NOTE: Any other retina isolation technique can be used depending on the researcher&#39;s preference.</li>
</ol>
6. Flat mounting of the retina
<ol>
	<li>Lay out the unfixed retina on a slide with a small amount of PBS. Using the micro-spatula, gently orient the retina with the vitreous side up. If the retina is folded inward, use micro-forceps to hold the edges of the retina while the retina is unfolded using the micro-spatula.</li>
	<li>Make 4-5 radial cuts into the retina so that it lies flat (cloverleaf pattern).</li>
	<li>Using a lint-free tissue, dry up the excess of PBS away from the retina. 
	NOTE: Do not touch the retina with the tissue; otherwise, the sample will be lost. Coverslipping is desirable to keep the retina flat.</li>
</ol>
7. Microscopy
NOTE: Any fluorescence microscope with a GFP/FITC (480/530 nm) channel can be used for this step. For this work, we used the referenced microscope with 488 channel and associated software for image acquisition.
<ol>
	<li>Observe the recently flat-mounted retina under the microscope at 100x magnification (10x objective) and count fluorescently labeled leukocytes (manually) by methodically scanning the entire tissue (right to left or top to bottom). 
	NOTE: Leukocytes are single fluorescent dots that can display a round or oval shape. They are 12-15 &#181;m in diameter and do not protrude from the retinal capillaries (the structure is completely constrained by the lumen of the vessel).</li>
	<li>Acquire representative images with the desired magnification and perform postprocessing of the images with the software of choice (e.g., ImageJ [Fiji]).</li>
	<li>Express the count as leukocytes per retina. Graph the data by mean &#177; standard deviation.</li>
</ol>

<ol><li>Swystun, L. L., Liaw, P. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+role+of+leukocytes+in+thrombosis%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">The role of leukocytes in thrombosis.</a> Blood. 128 (6), 753-762 (2016).</li>
<li>Barouch, F. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Integrin-mediated+neutrophil+adhesion+and+retinal+leukostasis+in+diabetes%5BTitle%5D)+AND+%22Invest+Ophthalmol+Vis+Sci%22%5BJournal%5D)">Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.</a> Invest Ophthalmol Vis Sci. 41 (5), 1153-1158 (2000).</li>
<li>Macaron, W., Sargsyan, Z., Short, N. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hyperleukocytosis+and+leukostasis+in+acute+and+chronic+leukemias%5BTitle%5D)+AND+%22Leuk+Lymphoma%22%5BJournal%5D)">Hyperleukocytosis and leukostasis in acute and chronic leukemias.</a> Leuk Lymphoma. 63 (8), 1780-1791 (2022).</li>
<li>Kempen, J. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+prevalence+of+diabetic+retinopathy+among+adults+in+the+United+States%5BTitle%5D)+AND+%22Arch+Ophthalmol%22%5BJournal%5D)">The prevalence of diabetic retinopathy among adults in the United States.</a> Arch Ophthalmol. 122 (4), 552-563 (2004).</li>
<li>Kohner, E. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Diabetic+retinopathy%5BTitle%5D)+AND+%22Br+Med+Bull%22%5BJournal%5D)">Diabetic retinopathy.</a> Br Med Bull. 45 (1), 148-173 (1989).</li>
<li>Aouiss, A., Anka Idrissi, D., Kabine, M., Zaid, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Update+of+inflammatory+proliferative+retinopathy%3A+Ischemia%2C+hypoxia+and+angiogenesis%5BTitle%5D)+AND+%22Curr+Res+Transl+Med%22%5BJournal%5D)">Update of inflammatory proliferative retinopathy: Ischemia, hypoxia and angiogenesis.</a> Curr Res Transl Med. 67 (2), 62-71 (2019).</li>
<li>Tsalamandris, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+role+of+inflammation+in+diabetes%3A+Current+concepts+and+future+perspectives%5BTitle%5D)+AND+%22Eur+Cardiol%22%5BJournal%5D)">The role of inflammation in diabetes: Current concepts and future perspectives.</a> Eur Cardiol. 14 (1), 50-59 (2019).</li>
<li>Adamis, A. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Is+diabetic+retinopathy+an+inflammatory+disease%5BTitle%5D)+AND+%22Br+J+Ophthalmol%22%5BJournal%5D)">Is diabetic retinopathy an inflammatory disease.</a> Br J Ophthalmol. 86 (4), 363-365 (2002).</li>
<li>Joussen, A. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+central+role+for+inflammation+in+the+pathogenesis+of+diabetic+retinopathy%5BTitle%5D)+AND+%22FASEB+J%22%5BJournal%5D)">A central role for inflammation in the pathogenesis of diabetic retinopathy.</a> FASEB J. 18 (12), 1450-1452 (2004).</li>
<li>Serra, A. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((CD11b%2B+bone+marrow-derived+monocytes+are+the+major+leukocyte+subset+responsible+for+retinal+capillary+leukostasis+in+experimental+diabetes+in+mouse+and+express+high+levels+of+CCR5+in+the+circulation%5BTitle%5D)+AND+%22Am+J+Pathol%22%5BJournal%5D)">CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation.</a> Am J Pathol. 181 (2), 719-727 (2012).</li>
<li>Kinukawa, Y., Shimura, M., Tamai, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Quantifying+leukocyte+dynamics+and+plugging+in+retinal+microcirculation+of+streptozotosin-induced+diabetic+rats%5BTitle%5D)+AND+%22Curr+Eye+Res%22%5BJournal%5D)">Quantifying leukocyte dynamics and plugging in retinal microcirculation of streptozotosin-induced diabetic rats.</a> Curr Eye Res. 18 (1), 49-55 (1999).</li>
<li>Linsenmeier, R. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Retinal+hypoxia+in+long-term+diabetic+cats%5BTitle%5D)+AND+%22Invest+Ophthalmol+Vis+Sci%22%5BJournal%5D)">Retinal hypoxia in long-term diabetic cats.</a> Invest Ophthalmol Vis Sci. 39 (9), 1647-1657 (1998).</li>
<li>Herdade, A. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Effects+of+diabetes+on+microcirculation+and+leukostasis+in+retinal+and+non-ocular+tissues%3A+Implications+for+diabetic+retinopathy%5BTitle%5D)+AND+%22Biomolecules%22%5BJournal%5D)">Effects of diabetes on microcirculation and leukostasis in retinal and non-ocular tissues: Implications for diabetic retinopathy.</a> Biomolecules. 10 (11), 1583(2020).</li>
<li>Oakley, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Incorporating+hemoglobin+levels+to+map+leukostasis+risk+in+acute+leukemia+using+microvasculature-on-chip+technologies%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">Incorporating hemoglobin levels to map leukostasis risk in acute leukemia using microvasculature-on-chip technologies.</a> Blood. 136 (Suppl 1), 9-10 (2020).</li>
<li>Miyamoto, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Prevention+of+leukostasis+and+vascular+leakage+in+streptozotocin-induced+diabetic+retinopathy+via+intercellular+adhesion+molecule-1+inhibition%5BTitle%5D)+AND+%22Proc+Natl+Acad+Sci+U+S+A%22%5BJournal%5D)">Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.</a> Proc Natl Acad Sci U S A. 96 (19), 10836-10841 (1999).</li>
<li>Veenstra, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Diabetic+retinopathy%3A+Retina-specific+methods+for+maintenance+of+diabetic+rodents+and+evaluation+of+vascular+histopathology+and+molecular+abnormalities%5BTitle%5D)+AND+%22Curr+Protoc+Mouse+Biol%22%5BJournal%5D)">Diabetic retinopathy: Retina-specific methods for maintenance of diabetic rodents and evaluation of vascular histopathology and molecular abnormalities.</a> Curr Protoc Mouse Biol. 5 (3), 247-270 (2015).</li>
<li>Lester, T. J., Johnson, J. W., Cuttner, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pulmonary+leukostasis+as+the+single+worst+prognostic+factor+in+patients+with+acute+myelocytic+leukemia+and+hyperleukocytosis%5BTitle%5D)+AND+%22Am+J+Med%22%5BJournal%5D)">Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis.</a> Am J Med. 79 (1), 43-48 (1985).</li>
<li>Porcu, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hyperleukocytic+leukemias+and+leukostasis%3A+a+review+of+pathophysiology%2C+clinical+presentation+and+management%5BTitle%5D)+AND+%22Leuk+Lymphoma%22%5BJournal%5D)">Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management.</a> Leuk Lymphoma. 39 (1-2), 1-18 (2000).</li>
<li>Giammarco, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hyperleukocytosis+and+leukostasis%3A+management+of+a+medical+emergency%5BTitle%5D)+AND+%22Expert+Rev+Hematol%22%5BJournal%5D)">Hyperleukocytosis and leukostasis: management of a medical emergency.</a> Expert Rev Hematol. 10 (2), 147-154 (2017).</li>
<li>Mank, V., Azhar, W., Brown, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Leukocytosis%5BTitle%5D)+AND+%22StatPearls%22%5BJournal%5D)">Leukocytosis.</a> StatPearls. , StatPearls Publishing. Treasure Island (FL). (2024).</li>
<li>Bernhard, W., Avrameas, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ultrastructural+visualization+of+cellular+carbohydrate+components+by+means+of+concanavalin+A%5BTitle%5D)+AND+%22Exp+Cell+Res%22%5BJournal%5D)">Ultrastructural visualization of cellular carbohydrate components by means of concanavalin A.</a> Exp Cell Res. 64 (1), 232-236 (1971).</li>
<li>Oliver, J. M., Zurier, R. B., Berlin, R. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Concanavalin+a+cap+formation+on+polymorphonuclear+leukocytes+of+normal+and+beige+%28chediak-higashi%29+mice%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Concanavalin a cap formation on polymorphonuclear leukocytes of normal and beige (chediak-higashi) mice.</a> Nature. 253 (5491), 471-473 (1975).</li>
<li>Pink, J. R., Hoessli, D., Tartakoff, A., Hooghe, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Characterisation+of+Concanavalin+A-binding+glycoproteins+from+mouse+splenic+leukocytes+by+two-dimensional+electrophoresis%3A+preferential+binding+of+incompletely+glycosylated+forms+of+H-2+antigen+to+the+lectin%5BTitle%5D)+AND+%22Mol+Immunol%22%5BJournal%5D)">Characterisation of Concanavalin A-binding glycoproteins from mouse splenic leukocytes by two-dimensional electrophoresis: preferential binding of incompletely glycosylated forms of H-2 antigen to the lectin.</a> Mol Immunol. 20 (4), 491-497 (1983).</li>
<li>Janssen, B., Debets, J., Leenders, P., Smits, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Chronic+measurement+of+cardiac+output+in+conscious+mice%5BTitle%5D)+AND+%22Am+J+Physiol+Regul+Integr+Comp+Physiol%22%5BJournal%5D)">Chronic measurement of cardiac output in conscious mice.</a> Am J Physiol Regul Integr Comp Physiol. 282 (3), R928-R935 (2002).</li>
<li>Flecknell, P. A. Anaesthesia of common laboratory species: Special considerations. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aFlecknell%2C+PA+%22Laboratory+Animal+Anaesthesia%22">Laboratory Animal Anaesthesia</a>. Flecknell, P. A. , 3rd Edition, Academic Press. 181-241 (2009).</li>
<li>Seemann, S., Zohles, F., Lupp, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Comprehensive+comparison+of+three+different+animal+models+for+systemic+inflammation%5BTitle%5D)+AND+%22J+Biomed+Sci%22%5BJournal%5D)">Comprehensive comparison of three different animal models for systemic inflammation.</a> J Biomed Sci. 24 (1), 60(2017).</li>
<li>Lessieur, E. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((ICAM-1+on+the+luminal+surface+of+endothelial+cells+is+induced+to+a+greater+extent+in+mouse+retina+than+in+other+tissues+in+diabetes%5BTitle%5D)+AND+%22Diabetologia%22%5BJournal%5D)">ICAM-1 on the luminal surface of endothelial cells is induced to a greater extent in mouse retina than in other tissues in diabetes.</a> Diabetologia. 65 (10), 1734-1744 (2022).</li>
<li>Kuwabara, T., Cogan, D. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Studies+of+retinal+vascular+patterns%3A+I.+Normal+architecture%5BTitle%5D)+AND+%22Arch+Ophthalmol%22%5BJournal%5D)">Studies of retinal vascular patterns: I. Normal architecture.</a> Arch Ophthalmol. 64, 904-911 (1960).</li>
<li>Tigner, A., Ibrahim, S. A., Murray, I. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Histology%2C+white+blood+cell%5BTitle%5D)+AND+%22StatPearls%22%5BJournal%5D)">Histology, white blood cell.</a> StatPearls. , StatPearls Publishing. Treasure Island, FL. (2024).</li>
</ol>

The authors have no conflicts of interest to declare.

Leukostasis in humans refers to symptoms and clinical findings associated with hyperleukocytosis (total leukocytes (WBCs) count &#62;100,000/&#181;L) and is a medical emergency20. The mechanism(s) that lead to leukostasis are under intensive research. To date, the study of leukostasis in humans in vivo is not yet possible and researchers need to rely on animal models to understand this process. Different diseases present leukostasis and having a detailed protocol to visualize the phenomen...

Leukocytes (white blood cells, WBCs) play an&#160;important role in&#160;the optimal function of the vasculature such as maintenance of the blood fluidity and regulation of thrombus resolution1. They also play a key role in some&#160;pathological&#160;conditions, such as adhering to the luminal wall of the vasculature for prolonged periods of time leading&#160;to&#160;vessel&#160;obstruction, at least temporarily, a phenomenon known as leukostasis2,3.
Diabetic retinopathy is one of the most common complications of long-term diabetes and one of the leading causes of visual impairment and blindness in the US and worldwide for individuals 20-75 years of age4. Slow and progressive degeneration of the retinal vasculature is a clinically meaningful component of the early stages of the disease, which in some patients leads to retinal ischemia with the resulting retinal neovascularization5,6. Cumulative evidence indicates that inflammation plays an important role in the development of the retinopathy7, and leukostasis is considered a subclinical intravascular inflammatory response. Leukostasis occurs in the early stages of diabetes, well before any detectable clinical manifestations have developed8,9,10. The repeated plugging of the retinal vessels by adherent leukocytes over months to years (chronic leukostasis) in diabetes might contribute to the vascular occlusion and degeneration of the capillaries11,12,13. The severity of this leukostasis is of pathologic significance and can be used to monitor the severity of the disease process or to evaluate the efficacy of a therapy in research settings.
To further study the specific effects of the hyperglycemic microenvironment on leukostasis, in vitro models have been designed. Isolated retinal microvascular endothelial cells can be grown and arranged either in 2- or 3-D cultures models (microvasculature-on-a-chip14) to replicate the vascular endothelium (the cell monolayer that paves the lumen of the vessels). However, the interexperimental variation of these models limits their use. The study of leukostasis in human retinal vasculature in vivo is still limited, and therefore, most of the current knowledge on retinal leukostasis is derived from animal models of diabetic retinopathy13,15.
The aim of this report is to describe a standard protocol based on methods described elsewhere16 for the quantification of attached leukocytes to the retinal vasculature as a parameter of leukostasis. This assay can be used to study other vascular diseases that also present leukostasis, such as malignancies3,17,18,19 and some infectious and allergic conditions20. This protocol can be implemented in any basic research laboratory without the need of specialized equipment. In the method summarized below, the vasculature is initially perfused with buffer to remove blood, and then, concanavalin A is perfused into the vasculature where it binds to all exposed cell walls and causes especially bright staining of leukocytes21,22,23. If the perfusion to remove all unbound blood cells is successful, the remaining fluorescently labeled leukocytes that are bound to the vasculature can be manually quantified using any fluorescence microscope on hand.

<table><tbody><tr><td>10 mL syringe</td><td></td><td></td><td></td></tr><tr><td>4-way stopcock Luer lock I.V. line valve</td><td>Baxter</td><td>2C6204</td><td></td></tr><tr><td>Concanavalin A solution</td><td>Vector&amp;nbsp;</td><td>FL-1001</td><td>Prepare in PBS 1 mg/mL</td></tr><tr><td>Dissecting tools set</td><td></td><td></td><td>Includes hemostats, scissors and forceps</td></tr><tr><td>FIJI</td><td></td><td></td><td>Software for image processing</td></tr><tr><td>Fluorescence microscope</td><td>Nikon</td><td>Eclipse Ni</td><td></td></tr><tr><td>Forceps, Dumont #5, Biological grade tip</td><td>Electron Microscopy Sciences (EMS)</td><td>72700-D</td><td></td></tr><tr><td>Gavage Needle 1.25 mm OD barrel tip x 30 mm</td><td>Fine Science</td><td>18060-20</td><td></td></tr><tr><td>Halstead Mosquito Forceps</td><td>Fisher Scientific</td><td>13-812-10</td><td></td></tr><tr><td>I.V. Catheter set with regulating clamp 70 inches</td><td>Baxter</td><td>2C5417s</td><td></td></tr><tr><td>I.V. Pole</td><td></td><td></td><td></td></tr><tr><td>Lint free tissue</td><td></td><td></td><td>Kimpwipes is an option</td></tr><tr><td>Micro dissecting spring scissors, Vannas, 3 mm straight</td><td>ROBOZ</td><td>RS-5620</td><td></td></tr><tr><td>Micro spatula</td><td>Fine Science Tools (FST)</td><td>10091-12</td><td></td></tr><tr><td>Nikon</td><td></td><td>NIS-Elements (AR 5.30.03 64-bit)</td><td>Software for image acquisition</td></tr><tr><td>Petri dish (100 mmx15 mm)</td><td>Corning</td><td>351029</td><td></td></tr><tr><td>Phosphate buffered saline (PBS)</td><td></td><td></td><td></td></tr><tr><td>Pink dental wax</td><td>Electron Microscopy Sciences (EMS)</td><td>72670</td><td></td></tr><tr><td>Pressure infuser</td><td>Infusurge</td><td>4010</td><td></td></tr><tr><td>Razor blades, GEM single edge stainless steel, Teflon coated</td><td>Electron Microscopy Sciences (EMS)</td><td>71970</td><td></td></tr><tr><td>Saline 0.9%, veterinary grade, 1000 mL</td><td>Baxter</td><td>04925-04-10</td><td></td></tr><tr><td>Small dissecting scissors, curved blunt end 22 mm</td><td>ROBOZ</td><td>RS 5983</td><td></td></tr></tbody></table>

quantification of diabetes-induced adherent leukocytes in retinal vasculature

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Leukostasis refers to the attachment of leukocytes to the luminal wall of the vasculature. This interaction of leukocytes with the wall of blood vessels is characteristic of inflammation and has been causally linked to capillary occlusion in a variety of tissues and diseases, including diabetic retinopathy. 
Leukostasis has been reported for years as a life-threatening complication of hyperleukocytosis and can only be diagnosed clinically. Given the importance of the phenomenon, intensive research has been done to understand the potential mechanism(s) that lead to its manifestation; however, there is no gold-standard technique in laboratory settings to visualize and quantify the severity of the event.
In the method summarized below, the vasculature is initially perfused with a buffer to remove blood, and then, concanavalin A is perfused into the vasculature where it binds to all exposed cell walls and causes especially bright staining of leukocytes. If the perfusion to remove all unbound blood cells was successful, the remaining fluorescently labeled leukocytes are bound to the vasculature, and they can be manually quantified using any available fluorescence microscope.

A well-executed perfusion and staining protocol will show the complete retinal vasculature delineated with concanavalin A (Figure 1). Poor perfusion of the mouse prevents labeling of the entire vascular tree and subsequent analysis of the leukocytes adherent to the lumen (Figure 2), whereas excessive pressure from a rapid squeeze of a syringe (less than 30-35 s) can cause vascular permeability and bursting of the blood vessels (Figure 3</str...

We demonstrate a method to label the walls of the retinal vasculature and adherent leukocytes. These adherent leukocytes can then be counted under a fluorescence microscope as a parameter of inflammation or the response of that inflammation to therapies.

Leukostasis refers to the attachment of leukocytes to the luminal wall of the vasculature. This interaction of leukocytes with the wall of blood vessels ...

quantification-diabetes-induced-adherent-leukocytes-retinal

Research

JoVE Journal

Medicine

Source: Lani-Louzada, R., et al.  Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents. J. Vis. Exp. (2022).This video demonstrates the quantification of retinal ganglion cells from chemically fixed rat retinas subjected to full-circle cauterization of the limbal vascular plexus. The process includes permeabilization, antibody staining, and nuclear counterstaining, followed by visualization under an epifluorescence microscope to assess the impact of...

Quantification of Retinal Ganglion Cell Somas Following Cauterization-Induced Ocular Hypertension 

Intravital microscopy can be used in animals to visualize and measure retinal vascular diameters, bloodstream velocities, and total retinal blood flow.

Intravital Video Microscopy Measurements of Retinal Blood Flow in Mice

We report an in vitro method that allows the quantitation of the actual number of adhesive cells within an endothelial cell monolayer.

Quantitation of Endothelial Cell Adhesiveness In Vitro

The retina shares prominent similarities with the brain and thus represents a unique window to study vasculature and neuronal structure in the brain non-invasively. This protocol describes a method to study dementia using retinal imaging techniques. This method can potentially aid in diagnosis and risk assessment of dementia.

Using Retinal Imaging to Study Dementia

Here, we discuss a method protocol which will allow an easy analysis of the adult tg(fli:EGFP) zebrafish retinal vasculature as a fast read-out in settings of long-term vascular pathologies linked to neoangiogenesis and structural changes.

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature

We demonstrate three different tissue preparation techniques for immunohistochemical visualization of rat retinal microvascular pericytes, i.e., cryo-sections, whole-mounts, and hypotonic isolation of the vascular network.

Retinal Cryo-sections, Whole-Mounts, and Hypotonic Isolated Vasculature Preparations for Immunohistochemical Visualization of Microvascular Pericytes

This study aims to develop a novel human organotypic retinal culture (HORC) model that prevents compromising retinal integrity during explant handling. This is achieved by culturing the retina with the overlying vitreous and the underlying retinal pigment epithelium-choroid (RPE-choroid) and sclera.

Characterization of a Novel Human Organotypic Retinal Culture Technique

Diabetic retinopathy is one of the leading causes of blindness. Histology, blood-retinal barrier breakdown assay, and fluorescence angiography are valuable techniques to understand the pathophysiology of the retina, which could further enhance the efficient drug screening against diabetic retinopathy.

Retinal Pathophysiological Evaluation in a Rat Model

This article describes a well-established and reproducible lectin stain assay for the whole mount retinal preparations and the protocols required for the quantitative measurement of vascular parameters frequently altered in proliferative and non-proliferative retinopathies.

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies

The streptozotocin-induced diabetic wound model in male SD rats is currently the most widely used model for studying wound healing in type I diabetes mellitus. This protocol describes the methods used to construct this model. It also presents and addresses potential challenges and examines the progression and angiogenic characteristics of diabetic wounds.

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A protection assay was developed to monitor the retinal vasculature's resilience to death from diabetes/diabetic retinopathy-related insults such as oxidative stress and cytokines.

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Learn to quantify adherent leukocytes in retinal vasculature using fluorescence microscopy and concanavalin A perfusion in mice. This method enables assessment of inflammation and therapeutic efficacy in diabetic retinopathy research.

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Explore More Videos